Abstract
BackgroundMismatch repair deficiency (dMMR) is a well-recognized biomarker for response to immune checkpoint blockade (ICB). Strategies to convert MMR-proficient (pMMR) to dMMR phenotype with the goal of sensitizing tumors to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have